MXPA04012630A - Proceso para preparar derivados de acido 5-(1,3-oxazol-2-il)benzoico. - Google Patents
Proceso para preparar derivados de acido 5-(1,3-oxazol-2-il)benzoico.Info
- Publication number
- MXPA04012630A MXPA04012630A MXPA04012630A MXPA04012630A MXPA04012630A MX PA04012630 A MXPA04012630 A MX PA04012630A MX PA04012630 A MXPA04012630 A MX PA04012630A MX PA04012630 A MXPA04012630 A MX PA04012630A MX PA04012630 A MXPA04012630 A MX PA04012630A
- Authority
- MX
- Mexico
- Prior art keywords
- oxazol
- preparing
- benzoic acid
- acid derivatives
- formula iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
Se describen compuestos de formula III y un proceso para preparar un compuesto de formula III, en donde R1, R2, R3 y R6 se define en la presente, utilizando un aducto de cloruro de zinc/oxazol opcionalmente sustituido y un compuesto de formula I. Se describen otros metodos para utilizar compuestos de formula III para preparar compuestos utiles en el tratamiento de la enfermedad de Alzheimer y condiciones relacionadas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39028502P | 2002-06-20 | 2002-06-20 | |
US45047803P | 2003-02-27 | 2003-02-27 | |
PCT/US2003/019585 WO2004000821A1 (en) | 2002-06-20 | 2003-06-20 | Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04012630A true MXPA04012630A (es) | 2005-09-30 |
Family
ID=30003150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04012630A MXPA04012630A (es) | 2002-06-20 | 2003-06-20 | Proceso para preparar derivados de acido 5-(1,3-oxazol-2-il)benzoico. |
Country Status (18)
Country | Link |
---|---|
US (2) | US7115747B2 (es) |
EP (1) | EP1532123B1 (es) |
JP (1) | JP2005533811A (es) |
CN (1) | CN1324017C (es) |
AT (1) | ATE370131T1 (es) |
AU (1) | AU2003249344A1 (es) |
BR (1) | BR0312439A (es) |
CA (1) | CA2489988A1 (es) |
CO (1) | CO5670350A2 (es) |
DE (1) | DE60315664D1 (es) |
EA (1) | EA008389B1 (es) |
HK (1) | HK1081543A1 (es) |
IL (1) | IL165763A0 (es) |
MX (1) | MXPA04012630A (es) |
NO (1) | NO20045497L (es) |
NZ (1) | NZ537390A (es) |
PL (1) | PL374999A1 (es) |
WO (1) | WO2004000821A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1565428A1 (en) * | 2002-11-27 | 2005-08-24 | Elan Pharmaceuticals, Inc. | Substituted ureas and carbamates |
TW200738701A (en) * | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
US7838676B2 (en) | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
AU2006316620B2 (en) | 2005-11-21 | 2011-03-03 | Amgen Inc. | Beta-secretase modulators and methods of use |
US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
WO2008137954A2 (en) * | 2007-05-07 | 2008-11-13 | Environmental Packaging Technologies Limited | Universal shipping container |
CA2687608C (en) | 2007-05-25 | 2013-07-02 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
WO2008147547A1 (en) | 2007-05-25 | 2008-12-04 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
PE20110805A1 (es) | 2008-09-11 | 2011-11-09 | Amgen Inc | Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso |
US9296698B2 (en) | 2009-11-23 | 2016-03-29 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
EP2504330A1 (en) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
CA2788363A1 (en) | 2010-01-19 | 2011-07-28 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
WO2011115938A1 (en) | 2010-03-15 | 2011-09-22 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta - secretase modulators |
US8497264B2 (en) | 2010-03-15 | 2013-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
WO2012109165A1 (en) | 2011-02-07 | 2012-08-16 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
US9462841B1 (en) | 2016-03-01 | 2016-10-11 | William Popejoy | Protective headgear and shoulder pad apparatus and methods |
US11272751B2 (en) | 2016-03-01 | 2022-03-15 | Nicholas Popejoy | Protective headgear, impact diffusing systems and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
CA2462851A1 (en) | 2001-10-04 | 2003-04-10 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
MXPA04004428A (es) * | 2001-11-08 | 2004-09-10 | Elan Pharm Inc | Derivados de 2,3-diamino-2-hidroxipropano n,n`-sustituidos. |
GB0325830D0 (en) * | 2003-11-05 | 2003-12-10 | Novartis Ag | Organic compounds |
-
2003
- 2003-06-20 CA CA002489988A patent/CA2489988A1/en not_active Abandoned
- 2003-06-20 JP JP2004516055A patent/JP2005533811A/ja active Pending
- 2003-06-20 MX MXPA04012630A patent/MXPA04012630A/es active IP Right Grant
- 2003-06-20 NZ NZ537390A patent/NZ537390A/en unknown
- 2003-06-20 BR BR0312439-8A patent/BR0312439A/pt not_active IP Right Cessation
- 2003-06-20 WO PCT/US2003/019585 patent/WO2004000821A1/en active IP Right Grant
- 2003-06-20 US US10/600,100 patent/US7115747B2/en not_active Expired - Fee Related
- 2003-06-20 DE DE60315664T patent/DE60315664D1/de not_active Expired - Lifetime
- 2003-06-20 CN CNB038144476A patent/CN1324017C/zh not_active Expired - Fee Related
- 2003-06-20 PL PL03374999A patent/PL374999A1/xx unknown
- 2003-06-20 AT AT03761206T patent/ATE370131T1/de not_active IP Right Cessation
- 2003-06-20 AU AU2003249344A patent/AU2003249344A1/en not_active Abandoned
- 2003-06-20 EA EA200401510A patent/EA008389B1/ru unknown
- 2003-06-20 EP EP03761206A patent/EP1532123B1/en not_active Expired - Lifetime
-
2004
- 2004-12-14 IL IL16576304A patent/IL165763A0/xx unknown
- 2004-12-16 NO NO20045497A patent/NO20045497L/no not_active Application Discontinuation
-
2005
- 2005-01-20 CO CO05004558A patent/CO5670350A2/es not_active Application Discontinuation
-
2006
- 2006-02-07 HK HK06101593A patent/HK1081543A1/xx not_active IP Right Cessation
- 2006-10-03 US US11/538,155 patent/US20070105921A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040063965A1 (en) | 2004-04-01 |
NZ537390A (en) | 2006-07-28 |
AU2003249344A1 (en) | 2004-01-06 |
JP2005533811A (ja) | 2005-11-10 |
NO20045497D0 (no) | 2004-12-16 |
ATE370131T1 (de) | 2007-09-15 |
EA008389B1 (ru) | 2007-04-27 |
BR0312439A (pt) | 2005-05-10 |
EA200401510A1 (ru) | 2005-06-30 |
CA2489988A1 (en) | 2003-12-31 |
PL374999A1 (en) | 2005-11-14 |
EP1532123A1 (en) | 2005-05-25 |
NO20045497L (no) | 2005-03-07 |
US7115747B2 (en) | 2006-10-03 |
DE60315664D1 (de) | 2007-09-27 |
US20070105921A1 (en) | 2007-05-10 |
CO5670350A2 (es) | 2006-08-31 |
HK1081543A1 (en) | 2006-05-19 |
CN1662510A (zh) | 2005-08-31 |
EP1532123B1 (en) | 2007-08-15 |
CN1324017C (zh) | 2007-07-04 |
WO2004000821A1 (en) | 2003-12-31 |
IL165763A0 (en) | 2006-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1081543A1 (en) | Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives | |
MY142768A (en) | Gfat inhibitors | |
MY142807A (en) | Benzimidazole derivative and use thereof. | |
WO2003103653A8 (en) | METHODS OF TREATING ALZHEIMER'S DISEASE WITH ALKANOIC ARYL ACID AMIDES | |
EA200101194A1 (ru) | Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств | |
WO2004094384A3 (en) | (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease | |
TW200510405A (en) | Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors | |
MY136761A (en) | Oxazol derivatives | |
GB0225474D0 (en) | Therapeutic agents | |
GB0223038D0 (en) | Therapeutic compounds | |
TW200505418A (en) | Phenacyl 2-hydroxy-3-diaminoalkanes | |
GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
SG160195A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
WO2004024081A3 (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
IL192253A0 (en) | Substituted cyclohexylmethyl derivatives | |
TW200740827A (en) | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | |
PT1709027E (pt) | Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento de doenças cardiovasculares | |
TW200503712A (en) | (2-carboxamido)(3-amino)thiophene compounds | |
PL1685142T3 (pl) | Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera | |
NO20065902L (no) | 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
ATE374773T1 (de) | Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten | |
MXPA04005940A (es) | Acidos 3-(imidazolil)-2-aminopropanoicos. | |
TW200637856A (en) | Process for producing thiazolidinedion compound and intermediate thereof | |
EP1036793A3 (en) | A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative | |
DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |